About J B Chemicals & Pharmaceuticals Ltd 
J B Chemicals & Pharmaceuticals Ltd
Large Cap
Pharmaceuticals & Drugs
J B Chemicals & Pharmaceuticals (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals in December 18th, 1976. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and APIs. The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman. The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
Company Coordinates 
Company Details
Neelam Centre 4th Floor, B-Wing Hind Cycle Road Worli Mumbai Maharashtra : 400030
Registrar Details
Datamatics Financial Services Ltd , (Formerly Datamatics Financial Services Ltd) , Plot No A / 16 & A / 17, MIDC, Part B, Cross Lane, Marol , Andheri (E), Mumbai
Capital Structure 
Present Equity Capital
INR 15.53 Cr
Number of Shares
15.53 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
13-Sep-2024
15.53
15.53
20000
1
Issued under ESOP Scheme
27-Aug-2024
15.53
15.53
69850
1
Issued under ESOP Scheme
08-Aug-2024
15.52
15.52
11500
1
Issued under ESOP Scheme
04-Jun-2024
15.52
15.52
11582
1
Issued under ESOP Scheme
11-May-2024
15.52
15.52
6676
1
Issued under ESOP Scheme
05-Mar-2024
15.52
15.52
43450
1
Issued under ESOP Scheme
05-Feb-2024
15.52
15.52
107190
1
Issued under ESOP Scheme
29-Nov-2023
15.5
15.50
10210
1
Issued under ESOP Scheme
07-Nov-2023
15.5
15.50
78440
1
Issued under ESOP Scheme
18-Sep-2023
15.49
15.49
77464010
1
Stock Split
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 29 Schemes (14.57%)
FIIs
Held by 239 FIIs (14.64%)
Promoter with highest holding
Tau Investment Holdings Pte. Ltd. (53.66%)
Highest Public shareholder
Axis Mutual Fund Trustee Limited A/c Axis Mutual Fund A/c Axis Small Cap Fund (3.16%)
Individual Investors Holdings
13.42%
Management
Designation
Remuneration
Padmini Khare Kaicker
Non-Exec. & Independent Dir.
75.0 lacs
Sumit Bose
Non-Exec. & Independent Dir.
75.0 lacs
Ranjit Shahani.
Chairman & Independent Directo
80.0 lacs
Prashant Kumar.
Non-Exec & Non-Independent Dir
0
Nikhil Chopra
Whole Time Director & CEO
6.54 cr
GAURAV TREHAN
Non-Exec & Non-Independent Dir
0
SANDEEP PHADNIS
Company Sec. & Compli. Officer
0
Raw Materials Dashboard 
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of Traded Goods
167.3984
0%
Purchase of Traded Goods
Finished Goods Dashboard 
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceuticals
1,452.08
96.73%
Other Operating Revenues - Export Incentives
29.25
1.95%
Exchange Rate Difference
10.86
0.72%
Pharmaceuticals
Pharmaceuticals
Other Operating Revenues - Export Incentives
Other Operating Revenues - Export Incentives
Exchange Rate Difference
Exchange Rate Difference
Revenue and Profits:
Net Sales:
963 Cr
(Quarterly Results - Dec 2024)
Net Profit:
162 Cr
Pharmaceuticals & Drugs
INR 24,474 Cr (Large Cap)
37.00
33
0.99%
-0.10
19.03%
7.44